Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0620920210530071159
Experimental & Molecular Medicine
2021 Volume.53 No. 7 p.1159 ~ p.1169
Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue
Park Su-Jeong

Song Jin-Soo
Baek In-Jeoung
Jang Kyu-Yun
Han Chang-Yeob
Jun Dae-Won
Kim Peter K.
Raught Brian
Jin Eun-Jung
Abstract
In this study, we hypothesized that deregulation in the maintenance of the pool of coenzyme A (CoA) may play a crucial role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Specific deletion of Acot12 (Acot12?/?), the major acyl-CoA thioesterase, induced the accumulation of acetyl-CoA and resulted in the stimulation of de novo lipogenesis (DNL) and cholesterol biosynthesis in the liver. KEGG pathway analysis suggested PPAR¥á signaling as the most significantly enriched pathway in Acot12?/? livers. Surprisingly, the exposure of Acot12?/? hepatocytes to fenofibrate significantly increased the accumulation of acetyl-CoA and resulted in the stimulation of cholesterol biosynthesis and DNL. Interaction analysis, including proximity-dependent biotin identification (BioID) analysis, suggested that ACOT12 may directly interact with vacuolar protein sorting-associated protein 33A (VPS33A) and play a role in vesicle-mediated cholesterol trafficking and the process of lysosomal degradation of cholesterol in hepatocytes. In summary, in this study, we found that ACOT12 deficiency is responsible for the pathogenesis of NAFLD through the accumulation of acetyl-CoA and the stimulation of DNL and cholesterol via activation of PPAR¥á and inhibition of cholesterol trafficking.
KEYWORD
Disease model, Gene expression
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø